Jennifer L. Davis

Sits on 1 board. Last updated September 27, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: AbbVie Inc., 2 years.

AbbVie Inc. Director
2 years ยท Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
May 8, 2026 AbbVie Inc. Grant or award +1,118 โ€” โ€”
Dec 3, 2025 The Procter & Gamble Company Option exercise +60 $144.35 $8,723
Dec 3, 2025 The Procter & Gamble Company Shares withheld for tax โˆ’60 $144.35 $8,723
Oct 2, 2025 The Procter & Gamble Company Open-market sale โˆ’3,227 $152.23 $491,246
Aug 19, 2025 The Procter & Gamble Company Open-market sale โˆ’8,596 $157.27 $1,351,893
Aug 18, 2025 The Procter & Gamble Company Grant or award +21,518 โ€” โ€”
May 9, 2025 AbbVie Inc. Grant or award +1,203 โ€” โ€”
Apr 29, 2025 The Procter & Gamble Company Open-market sale โˆ’1,000 $161.38 $161,380
Dec 19, 2024 The Procter & Gamble Company Option exercise +46 $169.79 $7,856
Dec 19, 2024 The Procter & Gamble Company Shares withheld for tax โˆ’46 $169.79 $7,856
Oct 2, 2024 The Procter & Gamble Company Open-market sale โˆ’4,447 $171.65 $763,328
Aug 20, 2024 The Procter & Gamble Company Open-market sale โˆ’6,223 $169.22 $1,053,056
Aug 19, 2024 The Procter & Gamble Company Grant or award +15,971 โ€” โ€”
May 3, 2024 AbbVie Inc. Grant or award +1,322 โ€” โ€”
Dec 6, 2023 The Procter & Gamble Company Option exercise +48 $149.40 $7,108

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.